Michael Husseman
Pediatrics · Layton, UTNPI 1053319186
Payments from drug & device makers
$2,888,790in general payments, 2019–2025
Across 433 payments — averaging $6671.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.3M
- Novavax Inc$826K
- Sanofi Pasteur Inc.$608K
- AstraZeneca$110K
- Pfizer$36K
- GSK$18K
- plus $8K from 13 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 218 | $1,283,009 |
| Novavax Inc | 58 | $826,398 |
| Sanofi Pasteur Inc. | 51 | $607,796 |
| AstraZeneca | 23 | $109,817 |
| Pfizer | 19 | $35,779 |
| GSK | 16 | $18,287 |
| Astrazeneca UK Limited | 4 | $6,950 |
| Ironshore Pharmaceuticals Inc. | 10 | $181 |
| Tris Pharma Inc | 9 | $158 |
| Cranial Technologies, Inc | 6 | $102 |
| Corium, LLC | 4 | $74 |
| Neurelis, Inc. | 4 | $53 |
| Sobi, Inc | 3 | $49 |
| Seqirus USA Inc | 2 | $39 |
| Kyowa Kirin, Inc. | 2 | $34 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$2,888,790 in reported general payments places this provider in the 95th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Layton
- Nathan ForbushLayton$3.6M
- Robert HokiLayton$1.4M
- Laurent SiggLayton$1.2M
- Jennifer GilsoulLayton$559K
- Brent EberhardLayton$517K
- Colton RagsdaleLayton$348K
- Mari LuceLayton$289K
- Michael BurtonLayton$52K
- Alvin GabrielsenLayton$27K
- Jason HoaglandLayton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.